Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedle patch with or without triamcinolone versus triamcinolone injection for keloid treatment
IRCT20250228064873N2Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of triamcinolone in keloid (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Improvement of keloids according to the Vancouver Clinical Scoring System for Scars. Started Oct 2025; status: completed.
02
Drugs
triamcinolone
03
Conditions
keloid
Beyond the preview
Go deeper on IRCT20250228064873N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250228064873N2.